ArticlePharmaceutics2023

Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection.

Su-Hwa Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.